FIELD: biotechnology.
SUBSTANCE: group of inventions relates to biotechnology and can be used in medicine. Disclosed is a conjugate of an antibody targeting a tumour antigen with eribulin derivatives - cytotoxic agents acting on tubulin and preventing normal cell mitosis.
EFFECT: invention can be used in therapy of various malignant new growths.
56 cl, 7 ex, 11 tbl, 2 dwg
| Title |
Year |
Author |
Number |
| CONJUGATE OF ANTI-CLAUDIN ANTIBODY AND MEDICINAL AGENT AND PHARMACEUTICAL USE THEREOF |
2020 |
- Yang Yang
- Xu Jianyan
- Tao Weikang
|
RU2826119C1 |
| CONJUGATE OF TROP-2 ANTIBODY AND EXATECAN ANALOGUE AND MEDICAL USE THEREOF |
2021 |
- Yang Yang
- Hu Qiyue
- Tao Weikang
|
RU2830167C1 |
| CONJUGATE OF ANTI-CEA ANTIBODY AND EXCATECAN ANALOGUE AND PHARMACEUTICAL USE THEREOF |
2020 |
- Ying Hua
- Mao Langyong
- Wang Sijia
|
RU2833323C1 |
| ANTI-CLAUDIN 18.2 ANTIBODY AND USE THEREOF |
2020 |
- Yan, Yan
- Ge, Khu
- Tao, Vejkan
|
RU2822550C2 |
| ANTIBODY TO CD3 AND ITS PHARMACEUTICAL USE |
2019 |
- Ying Hua
- Zhang Ling
- Yang Xiaoying
- Ge Hu
- Tao Weikang
|
RU2802272C2 |
| PHARMACEUTICAL COMPOSITION CONTAINING ANTIBODY TO SOST, AND ITS USE |
2018 |
- Fang Jingjing
- Yan Zhen
- Liu Xun
|
RU2779430C2 |
| ANTIBODY TO PD-1, ITS ANTIGEN-BINDING FRAGMENT AND ITS PHARMACEUTICAL USE |
2020 |
- Gu Xiaoling
- Ye Xin
- Ge Hu
- Tao Weikang
|
RU2807484C2 |
| PHARMACEUTICAL COMPOSITION BASED ON ANTIBODIES AGAINST CD40 AND APPLICATION THEREOF |
2019 |
- Yang, Jianjian
- Li, Hao
- Liu, Xun
- Jiang, Jiahua
|
RU2778572C1 |
| PHARMACEUTICAL COMPOSITION BASED ON ANTIBODY TO PD-L1 AND ITS APPLICATION |
2018 |
- Yan, Zhen
- Yang, Jianjian
- Yan, Xiaodan
- Wu, Shan
- Liu, Xun
|
RU2766590C2 |
| CONNECTIVE TISSUE GROWTH FACTOR ANTIBODY AND USE THEREOF |
2020 |
- Fu, Yayuan
- Ma, Syaoli
- Ge, Khu
- Tao, Vejkan
|
RU2819228C2 |
